CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-11 | DUNN JOHN MICHAEL General Counsel and Secretary | Returned to the company · Stock Option (right to buy) | −45,000 | 0 | ||
| 2019-01-11 | DUNN JOHN MICHAEL General Counsel and Secretary | Grant or award · Restricted Stock Units | +724,848 | 724,848 | ||
| 2019-01-11 | Nash Duane President | Returned to the company · Stock Option (right to buy) | −93,377 | 0 | ||
| 2019-01-11 | Nash Duane President | Returned to the company · Stock Option (right to buy) | −23,344 | 0 | ||
| 2019-01-11 | Nash Duane President | Returned to the company · Stock Option (right to buy) | −241,670 | 0 | ||
| 2019-01-11 | Nash Duane President | Returned to the company · Stock Option (right to buy) | −85,000 | 0 | ||
| 2019-01-11 | Nash Duane President | Returned to the company · Stock Option (right to buy) | −85,000 | 0 | ||
| 2019-01-11 | Nash Duane President | Returned to the company · Common Stock | −85,000 | 0 | ||
| 2019-01-11 | Nash Duane President | Grant or award · Restricted Stock Units | +886,316 | 886,316 | ||
| 2018-09-25 | Halperin Errol R. Director | Sale | −89,417 | $0.29 | $26K | 0 |
| 2018-09-25 | Halperin Errol R. Director | Sale | −10,000 | $0.29 | $3K | 0 |
| 2018-09-24 | BIENAIME JEAN JACQUES Director | Sale | −26,619 | $0.30 | $8K | 18,500 |
| 2018-09-19 | Godshall Douglas Evan Director | Sale | −69,375 | $0.35 | $24K | 0 |
| 2018-09-17 | Satter Muneer A Director | Sale | −7,044,777 | $0.29 | $2.1M | 0 |
| 2018-09-14 | Satter Muneer A Director | Sale | −447,500 | $0.36 | $160K | 7,044,777 |
| 2018-09-13 | Satter Muneer A Director | Sale | −3,890,000 | $0.50 | $1.9M | 7,492,277 |
| 2018-09-13 | Hasnain Faheem Director | Sale | −59,200 | $0.44 | $26K | 122,743 |
| 2018-09-13 | Hasnain Faheem Director | Sale | −118,243 | $0.44 | $52K | 4,500 |
| 2018-09-13 | BIENAIME JEAN JACQUES Director | Sale | −20,000 | $0.47 | $9K | 45,119 |
| 2018-09-12 | Cohen Cheryl Director | Sale | −3,500 | $0.55 | $2K | 0 |
Page 13 of 16 · 311 trades